• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

闭塞性动脉硬化症(ASO)

[Arteriosclerosis obliterans (ASO)].

作者信息

Koshikawa Megumi, Ikeda Uichi

机构信息

Department of Cardiovascular Medicine, Shinshu University.

出版信息

Nihon Rinsho. 2010 May;68(5):926-9.

PMID:20446594
Abstract

The goal of treatment in arteriosclerosis obliterans (ASO) is to aggressively treat atherosclerotic risk factors to reduce future cardiovascular events as well as to improve symptoms of claudication and prevent limb amputation. Patients with ASO have an increased risk of cardiovascular events such as myocardial infarction and stroke in addition to significant impairment in their quality of life and physical function. Strategies for management of ASO include conservative treatment with risk factor modification, smoking cessation, exercise, pharmacologic therapy, balloon angioplasty and stenting of vessels, or bypass surgery, and therapeutic angiogenesis. In addition, the prevention and treatment for cardiovascular events such as myocardial infarction and stroke are important, too.

摘要

闭塞性动脉硬化(ASO)的治疗目标是积极治疗动脉粥样硬化危险因素,以减少未来心血管事件的发生,同时改善间歇性跛行症状并预防肢体截肢。除了生活质量和身体功能受到严重损害外,ASO患者发生心血管事件(如心肌梗死和中风)的风险也会增加。ASO的管理策略包括通过改变危险因素进行保守治疗、戒烟、运动、药物治疗、血管球囊血管成形术和支架置入术、旁路手术以及治疗性血管生成。此外,心肌梗死和中风等心血管事件的预防和治疗也很重要。

相似文献

1
[Arteriosclerosis obliterans (ASO)].闭塞性动脉硬化症(ASO)
Nihon Rinsho. 2010 May;68(5):926-9.
2
The clinical features and treatment of arteriosclerosis obliterans with diabetes.
Diabetes. 1996 Jul;45 Suppl 3:S101-4. doi: 10.2337/diab.45.3.s101.
3
Atherosclerosis obliterans of the lower extremities in Thai patients.泰国患者下肢动脉硬化闭塞症
J Med Assoc Thai. 2006 Oct;89(10):1612-20.
4
[Medical treatment of arteriosclerosis obliterans (ASO)].[闭塞性动脉硬化症(ASO)的医学治疗]
Nihon Geka Gakkai Zasshi. 1996 Jul;97(7):520-5.
5
[Arteriosclerosis obliterans].闭塞性动脉硬化
Nihon Rinsho. 1993 Aug;51(8):2160-4.
6
[Early detection and treatment of diseases of the arteries of the legs in patients with diabetes mellitus under ambulatory conditions].[糖尿病患者在门诊条件下腿部动脉疾病的早期检测与治疗]
Vestn Khir Im I I Grek. 1984 Aug;133(8):120-2.
7
[Diabetic angiopathies of the legs (clinical aspects, diagnosis and treatment)].[腿部糖尿病性血管病变(临床方面、诊断与治疗)]
Probl Endokrinol (Mosk). 1987 Nov-Dec;33(6):88-93.
8
Effects of low-density lipoprotein apheresis on plasma matrix metalloproteinase-9 and serum tissue inhibitor of metalloproteinase-1 levels in diabetic hemodialysis patients with arteriosclerosis obliterans.低密度脂蛋白分离术对合并闭塞性动脉硬化的糖尿病血液透析患者血浆基质金属蛋白酶-9及血清金属蛋白酶组织抑制因子-1水平的影响
ASAIO J. 2003 Jul-Aug;49(4):430-4.
9
[Identification and rehabilitation of high-risk patients in the prevention of atherosclerotic ulceration].[预防动脉粥样硬化性溃疡中高危患者的识别与康复]
Med Pregl. 1996;49(3-4):137-40.
10
[Endovascular treatment of multilevel arteriosclerosis obliterans of lower extremities].[下肢多节段动脉硬化闭塞症的血管内治疗]
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2010 Sep;24(9):1033-6.

引用本文的文献

1
Association Between Thromboelastography and Coagulation for Disease Severity Evaluation in Patients With Lower Extremity Arteriosclerosis Obliterans.血栓弹力图与凝血功能在下肢动脉硬化闭塞症患者疾病严重程度评估中的相关性
J Clin Lab Anal. 2025 Jan;39(2):e25138. doi: 10.1002/jcla.25138. Epub 2024 Dec 23.
2
CircHAT1 regulates the proliferation and phenotype switch of vascular smooth muscle cells in lower extremity arteriosclerosis obliterans through targeting SFRS1.环状HAT1通过靶向丝氨酸/精氨酸富集剪接因子1调控下肢动脉硬化闭塞症中血管平滑肌细胞的增殖和表型转换。
Mol Cell Biochem. 2025 Jan;480(1):203-215. doi: 10.1007/s11010-024-04932-2. Epub 2024 Feb 26.
3
Humanistic care interventions in patients with lower extremity arteriosclerosis obliterans.
下肢动脉硬化闭塞症患者的人文关怀干预措施
Am J Transl Res. 2021 Sep 15;13(9):10527-10535. eCollection 2021.